[1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate

C49H76N6O9 — CID 170255718

IUPAC[1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate
SMILESCC1CN1CC(COc1ccc(C(C)(C)c2ccc(OCC(CN3CC3C)OC(=O)NCCCCCCNC(=O)OC3CCCCC3)cc2)cc1)OC(=O)NCCCCCCNC=O
InChIInChI=1S/C49H76N6O9/c1-37-30-54(37)32-44(63-47(58)52-28-13-6-5-12-26-50-36-56)34-60-41-22-18-39(19-23-41)49(3,4)40-20-24-42(25-21-40)61-35-45(33-55-31-38(55)2)64-48(59)53-29-15-8-7-14-27-51-46(57)62-43-16-10-9-11-17-43/h18-25,36-38,43-45H,5-17,26-35H2,1-4H3,(H,50,56)(H,51,57)(H,52,58)(H,53,59)
InChIKeyUIEJDGAOLHFFGX-UHFFFAOYSA-N
MW893.18 g/mol
LogP7.29
Rot. Bonds30

About [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate

[1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate (PubChem CID 170255718) has the molecular formula C49H76N6O9 and a molecular weight of 893.18 g/mol. Its IUPAC name is [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate.

Molecular Properties

Compound Name[1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate
PubChem CID170255718
Molecular FormulaC49H76N6O9
Molecular Weight893.18 g/mol
Exact Mass892.57
IUPAC Name[1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate
SMILESCC1CN1CC(COc1ccc(C(C)(C)c2ccc(OCC(CN3CC3C)OC(=O)NCCCCCCNC(=O)OC3CCCCC3)cc2)cc1)OC(=O)NCCCCCCNC=O
InChIInChI=1S/C49H76N6O9/c1-37-30-54(37)32-44(63-47(58)52-28-13-6-5-12-26-50-36-56)34-60-41-22-18-39(19-23-41)49(3,4)40-20-24-42(25-21-40)61-35-45(33-55-31-38(55)2)64-48(59)53-29-15-8-7-14-27-51-46(57)62-43-16-10-9-11-17-43/h18-25,36-38,43-45H,5-17,26-35H2,1-4H3,(H,50,56)(H,51,57)(H,52,58)(H,53,59)
InChIKeyUIEJDGAOLHFFGX-UHFFFAOYSA-N
XLogP7.29
TPSA168.57 Ų
H-Bond Donors4
H-Bond Acceptors11
Rotatable Bonds30
Heavy Atoms64
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500893.18
LogP ≤ 57.29
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate?
The IUPAC name of [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate (CID 170255718) is [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate.
What is the SMILES notation for [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate?
The canonical SMILES for [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate is CC1CN1CC(COc1ccc(C(C)(C)c2ccc(OCC(CN3CC3C)OC(=O)NCCCCCCNC(=O)OC3CCCCC3)cc2)cc1)OC(=O)NCCCCCCNC=O.
What is the InChIKey of [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate?
The InChIKey is UIEJDGAOLHFFGX-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H76N6O9/c1-37-30-54(37)32-44(63-47(58)52-28-13-6-5-12-26-50-36-56)34-60-41-22-18-39(19-23-41)49(3,4)40-20-24-42(25-21-40)61-35-45(33-55-31-38(55)2)64-48(59)53-29-15-8-7-14-27-51-46(57)62-43-16-10-9-11-17-43/h18-25,36-38,43-45H,5-17,26-35H2,1-4H3,(H,50,56)(H,51,57)(H,52,58)(H,53,59).
What are the key properties of [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate?
[1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate has a molecular weight of 893.18 g/mol, XLogP of 7.29, 30 rotatable bonds, 4 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[4-[2-[4-[2-(6-formamidohexylcarbamoyloxy)-3-(2-methylaziridin-1-yl)propoxy]phenyl]propan-2-yl]phenoxy]-3-(2-methylaziridin-1-yl)propan-2-yl] N-[6-(cyclohexyloxycarbonylamino)hexyl]carbamate is sourced from PubChem (CID 170255718), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).